Publications of K.-A. Nave

Luo, L.; Ambrozkiewicz, M.; Benseler, F.; Chen, C.; Dumontier, E.; Falkner, S.; Furlanis, E.; Gomez, A. M.; Hoshina, N.; Huang, W.-H. et al.; Hutchison, M. A.; Itoh-Maruoka, Y.; Lavery, L. A.; Li, W.; Maruo, T.; Motohashi, J.; Pai, E. L.-L.; Pelkey, K. A.; Pereira, A.; Philips, T.; Sinclair, J. L.; Stogsdill, J. A.; Traunmüller, L.; Wang, J.; Wortel, J.; You, W.; Abumaria, N.; Beier, K. T.; Brose, N.; Burgess, H. A.; Cepko, C. L.; Cloutier, J.-F.; Eroglu, C.; Goebbels, S.; Kaeser, P. S.; Kay, J. N.; Lu, W.; Luo, L.; Mandai, K.; McBain, C. J.; Nave, K.-A.; Prado, M. A.M.; Prado, V. F.; Rothstein, J.; Rubenstein, J. L.R.; Saher, G.; Sakimura, K.; Sanes, J. R.; Scheiffele, P.; Takai, Y.; Umemori, H.; Verhage, M.; Yuzaki, M.; Zoghbi, H. Y.; Kawabe, H.; Craig, A. M.: Optimizing nervous system-specific gene targeting with Cre driver lines: prevalence of germline recombination and influencing factors. Neuron 106 (1), pp. 37 - 65.e5 (2020)

Stone, S.; Wu, S.; Nave, K.-A.; Lin, W.: The UPR preserves mature oligodendrocyte viability and function in adults by regulating autophagy of PLP. JCI Insight 5 (5), e132364 (2020)

Wakhloo, D.; Scharkowski, F.; Curto, Y.; Butt, U. J.; Bansal, V.; Steixner-Kumar, A. A.; Wüstefeld, L.; Rajput, A.; Arinrad, S.; Zillmann, M. R. et al.; Seelbach, A.; Hassouna, I.; Schneider, K.; Qadir Ibrahim, A.; Werner, H. B.; Werner, H. B.; Martens, H.; Miskowiak, K.; Wojcik, S. M.; Wojcik, S. M.; Bonn, S.; Nacher, J.; Nave, K. A.; Ehrenreich, H.: Functional hypoxia drives neuroplasticity and neurogenesis via brain erythropoietin. Nature Communications 11, 1313 (2020)

Kalinin, S.; Meares, G. P.; Lin, S. X.; Pietruczyk, E. A.; Saher, G.; Spieth, L.; Nave, K.-A.; Boullerne, A. I.; Lutz, S. E.; Benveniste, E. N. et al.; Feinstein, D. L.: Liver kinase B1 depletion from astrocytes worsens disease in a mouse model of multiple sclerosis. Glia 68 (3), pp. 600 - 616 (2020)

Cohen, C. C. H.; Popovic, M. A.; Klooster, J.; Weil, M.-T.; Möbius, W.; Nave, K.-A.; Kole, M. H. P.: Saltatory Conduction along Myelinated Axons Involves a Periaxonal Nanocircuit. Cell 180 (2), pp. 311 - 322.e15 (2020)

Fledrich, R.; Kungl, T.; Nave, K.-A.; Stassart, R. M.: Axo-glial interdependence in peripheral nerve development. Development 146 (21), dev151704 (2019)

Pan, H.; Oliveira, B.; Saher, G.; Dere, E.; Tapken, D.; Mitjans, M.; Seidel, J.; Wesolowski, J.; Wakhloo, D.; Klein-Schmidt, C. et al.; Ronnenberg, A.; Schwabe, K.; Trippe, R.; Mätz-Rensing, K.; Berghoff, S. A.; Al-Krinawe, Y.; Martens, H.; Begemann, M.; Stöcker, W.; Kaup, F.-J.; Mischke, R.; Boretius, S.; Nave, K.-A.; Krauss, J. K.; Hollmann, M.; Lühder, F.; Ehrenreich, H.: Uncoupling the widespread occurrence of anti-NMDAR1 autoantibodies from neuropsychiatric disease in a novel autoimmune model. Molecular Psychiatry 24 (10), pp. 1489 - 1501 (2019)

Werner, H. B.; Nave, K. A.: Enhanced actin dynamics: A therapeutic strategy for axonal regeneration? Neuron 103 (6), pp. 949 - 950 (2019)

Joseph, S.; Vingill, S.; Jahn, O.; Fledrich, R.; Werner, H. B.; Katona, I.; Möbius, W.; Mitkovski, M.; Huang, Y.; Weis, J. et al.; Sereda, M. W.; Schulz, J. B.; Nave, K.-A.; Stegmüller, J.: Myelinating glia-specific deletion of Fbxo7 in mice triggers axonal degeneration in the central nervous system together with peripheral neuropathy. The Journal of Neuroscience 39 (28), pp. 5606 - 5626 (2019)

Garcia-Agudo, L. F.; Janova, H.; Sendler, L. E.; Arinrad, S.; Steixner, A. A.; Hassouna, I.; Balmuth, E.; Ronnenberg, A.; Schopf, N.; van der Flier, F. J. et al.; Begemann, M.; Martens, H.; Weber, M. S.; Boretius, S.; Nave, K.-A.; Ehrenreich, H.: Genetically induced brain inflammation by Cnp deletion transiently benefits from microglia depletion. The FASEB Journal 33 (7), pp. 8634 - 8647 (2019)

Stumpf, S. K.; Berghoff, S. A.; Trevisiol, A.; Spieth, L.; Düking, T.; Schneider, L. V.; Schlaphoff, L.; Dreha-Kulaczewski, S.; Bley, A.; Burfeind, D. et al.; Kusch, K.; Mitkovski, M.; Ruhwedel, T.; Guder, P.; Röhse, H.; Denecke, J.; Gärtner, J.; Möbius, W.; Nave, K.-A.; Saher, G.: Ketogenic diet ameliorates axonal defects and promotes myelination in Pelizaeus-Merzbacher disease. Acta Neuropathologica 138, pp. 147 - 161 (2019)

Belin, S.; Ornaghi, F.; Shackleford, G. G.; Wang, J.; Scapin, C.; Lopez-Anido, C.; Silvestri, N.; Robertson, N.; Williamson, C.; Ishii, A. et al.; Taveggia, C.; Svaren, J.; Bansal, R.; Schwab, M. H.; Nave, K.; Fratta, P.; D'Antonio, M.; Poitelon, Y.; Feltri, M. L.; Wrabetz, L.: Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy. Human Molecular Genetics 28 (8), pp. 1260 - 1273 (2019)

Fledrich, R.; Akkermann, D.; Schütza, V.; Abdelaal, T. A. M.; Hermes, D.; Schäffner, E.; Soto Bernardini, M. C.; Götze, T.; Klink, A.; Kusch, K. et al.; Krueger, M.; Kungl, T.; Frydrychowicz, C.; Möbius, W.; Brück, W.; Mueller, W. C.; Bechmann, I.; Sereda, M. W.; Schwab, M. H.; Nave, K.-A.; Stassart, R. M.: NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathies. Nature Communications 10, 1467 (2019)

Lüders, K. A.; Nessler, S.; Kusch, K.; Patzig, J.; Jung, R. B.; Möbius, W.; Nave, K.-A.; Werner, H. B.: Maintenance of high proteolipid protein level in adult central nervous system myelin is required to preserve the integrity of myelin and axons. Glia 67 (4), pp. 634 - 649 (2019)

Scapin, C.; Ferri, C.; Pettinato, E.; Zambroni, D.; Bianchi, F.; Dell Carro, U.; Belin, S.; Caruso, D.; Mitro, N.; Pellegatta, M. et al.; Taveggia, C.; Schwab, M. H.; Nave, K.-A.; Feltri, M. L.; Wrabetz, L.; D'Antonio, M.: Enhanced axonal Neuregulin-1 type-III signaling ameliorates neurophysiology and hypomyelination in a Charcot-Marie-Tooth type 1B mouse model. Human Molecular Genetics 28 (6), pp. 992 - 1006 (2019)

Leitzen, E.; Raddatz, B. B.; Jin, W.; Goebbels, S.; Nave, K.-A.; Baumgärtner, W.; Hansmann, F.: Virus-triggered spinal cord demyelination is followed by a peripheral neuropathy resembling features of Guillain-Barré Syndrome. Scientific Reports 9, 4588 (2019)

Nave, K.-A.; Ehrenreich, H.: Time to revisit oligodendrocytes in multiple sclerosis. Nature Medicine 25 (3), pp. 364 - 366 (2019)

Erwig, M. S.; Patzig, J.; Steyer, A. M.; Dibaj, P.; Heilmann, M.; Heilmann, I.; Jung, R. B.; Kusch, K.; Möbius, W.; Jahn, O. et al.; Nave, K.-A.; Werner, H. B.: Anillin facilitates septin assembly to prevent pathological outfoldings of central nervous system myelin. eLife 8, e43888 (2019)

Prukop, T.; Stenzel, J.; Wernick, S.; Kungl, T.; Mroczek, M.; Adam, J.; Ewers, D.; Nabirotchkin, S.; Nave, K.-A.; Hajj, R. et al.; Cohen, D.; Sereda, M. W.: Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A). PLoS One 14 (1), e0209752 (2019)

Cathomas, F.; Azzinnari, D.; Bergamini, G.; Sigrist, H.; Buerge, M.; Hoop, V.; Wicki, B.; Goetze, L.; Soares, S.; Kukelova, D. et al.; Seifritz, E.; Goebbels, S.; Nave, K.-A.; Ghandour, S.; Seoighe, C.; Hildebrandt, T.; Leparc, G.; Klein, H.; Stupka, E.; Hengerer, B.; Pryce, C. R.: Oligodendrocyte gene expression is reduced by and influences effects of chronic social stress in mice. Genes, Brain and Behavior 18 (1), e12475 (2019)